Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has established a new subsidiary in Ghana. Going forward, the Company aims to reinforce distributor support and expand its business in the markets of West and Central Africa.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and the National Cancer Center (Location: Tokyo, Japan; President: Tomomitsu Hotta) have opened a joint research laboratory within the National Cancer Center Hospital (Location: Tokyo, Japan; Director: Yasuaki Arai) to promote joint development in the field of cancer diagnosis.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) have been selected by the Japan Investor Relations Association (JIRA) to receive its 20th “IR Grand Prix Award.” This is the first time Sysmex has won the IR Grand Prix Award, for which companies become eligible after they have won the Best IR Award twice in the past. Past award successes for Sysmex include 2004 (IR Award for Small to Medium Capitalization Companies), 2006 (Best IR Award) and 2011 (Best IR Award).
Bay of Plenty DHB has introduced an information-sharing system, BOP MEDCheck, utilising Eclair, to provide community pharmacists access to patients’ records and hospital clinician access to community dispensing information. Article reproduced courtesy of Pharmacy Today.
The requirement to manage an increasing workload while maintaining patient safety was the driver behind the decision to implement Sysmex’s Delphic AP Single Piece Workflow at Hawke’s Bay District Health Board’s histology laboratory. The laboratory has used Delphic AP software to manage its workflow processing and reporting for a number of years, but will be […]
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) plans to establish a new open innovation lab to accelerate R&D activities toward the realization of personalized medicine. The new lab will be located at Technopark (Nishi-ku, Kobe), Sysmex’s hub for R&D.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) is launching its new products in the sediment urinalysis testing field, the UF-5000/4000/3000 fully automated analyzers of formed elements in urine. The instruments will be rolled out successively on a global scale, beginning with the Japanese market in September 2015.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announced today the in-vitro diagnostic approval for manufacturing and sales of three platelet aggregation agonist reagent kits for use in the hemostasis field with Automated Blood Coagulation Analyzer CS-5100/2500/2400/2100i/2000i. This reagent kit allows automation of platelet aggregation testing with increased efficiency and standardization.
Sysmex Australia participated for the first time at the annual Health Informatics Conference in Brisbane – the ideal forum to introduce our health IT portfolio to a range of healthcare and informatics practitioners. For Australia, eHealth initiatives underpin the transformational change to the delivery of healthcare for the country and Sysmex are excited to be a part of this.
It’s just 18 months since Sysmex acquired flow cytometry specialists Partec, but the new company has clearly struck a chord with its (potential) clients. Specialists for cell counting in essential healthcare, research and industry, the company enjoyed an overly full booth at this year’s flow cytometry fair CYTO. Visitors were especially interested in the company’s […]